SEC Company Response from ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — Nov 1, 2017
ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: Nov. 1, 2017 · CIK: 0001326706 · Accession: 0001615774-17-006105
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218871
Letter
Re: NanoVibronix, Inc.
November 1, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-218871
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of NanoVibronix, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 5:00 p.m. (Washington, D.C. time) on Wednesday, November 1, 2017, or as soon as practicable thereafter.
In connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated October 31, 2017 were distributed to the following persons in the following approximate amounts:
To Whom Distributed Number of Copies
Institutions
Individuals 1,892
Total 1,942
We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson James Securities, Inc.
Show Raw Text
CORRESP
1
filename1.htm
November
1, 2017
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
NanoVibronix, Inc.
Registration Statement on Form S-1
File No. 333-218871
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins
the request of NanoVibronix, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared
effective at 5:00 p.m. (Washington, D.C. time) on Wednesday, November 1, 2017, or as soon as practicable thereafter.
In
connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated October
31, 2017 were distributed to the following persons in the following approximate amounts:
To Whom Distributed
Number of Copies
Institutions
50
Individuals
1,892
Total
1,942
We
have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson James Securities, Inc.
By:
/s/ Thomas W. Hands
Name:
Thomas W. Hands
Title:
President